Lipogems Product Treatment Increases the Proliferation Rate of Human Tendon Stem Cells without Affecting Their Stemness and Differentiation Capability

Table 1

Summary of the surface markers by cytofluorimetry of Lipogems-treated and control hTSCs. Numbers show the expression percentage for each cell surface protein.

Markers	hTSCs (control) (%)	hTSCs + Lipogems (%)
CD9	55.31	65.91
CD13	100	100
CD18	0	0
CD29	98.27	96.77
CD34	0	0
CD44	100	100
CD45	0	0
CD71	62.28	37.25
CD73	100	100
CD90	100	100
CD105	100	100
CD106	3.98	2.30
CD117	0	0
CD140a	0	0
CD140b	47.15	3.46
CD146	1.35	0
CD166	84.72	86.99
HLA-ABC	100	100
HLA-DR	0	0
Lineage	0.23	0
NG2	0	0
SSEA-4	0	0
Stro-1	0	0